So-Young Reports Unaudited Second Quarter 2024 Financial Results
So-Young International Inc. (Nasdaq: SY) reported its Q2 2024 financial results. Total revenues were RMB407.4 million (US$56.1 million), slightly down 1.1% year-over-year but exceeding guidance. The company achieved net income of RMB18.9 million (US$2.6 million), compared to a net loss in Q2 2023. Non-GAAP net income increased to RMB22.2 million (US$3.1 million).
Key highlights include a 22.6% increase in sales of medical products and maintenance services. The company opened 14 new clinics across eight core cities. However, average mobile MAUs decreased to 1.5 million from 3.0 million in Q2 2023. For Q3 2024, So-Young expects total revenues between RMB350.0 million and RMB370.0 million, representing a 9.2% to 4.0% year-over-year decrease.
So-Young International Inc. (Nasdaq: SY) ha riportato i risultati finanziari del Q2 2024. I ricavi totali sono stati di 407,4 milioni di RMB (56,1 milioni di dollari USA), leggermente in calo dell'1,1% rispetto all'anno precedente ma superiori alle previsioni. L'azienda ha registrato
Tra i punti salienti, si evidenzia un aumento del 22,6% nelle vendite di prodotti medicali e servizi di manutenzione. L'azienda ha aperto 14 nuove cliniche in otto città principali. Tuttavia, gli MAU mobili medi sono diminuiti a 1,5 milioni da 3,0 milioni nel Q2 2023. Per il Q3 2024, So-Young prevede ricavi totali compresi tra 350,0 milioni e 370,0 milioni di RMB, rappresentando una diminuzione rispetto all'anno precedente tra il 9,2% e il 4,0%.
So-Young International Inc. (Nasdaq: SY) informó sobre sus resultados financieros del Q2 2024. Los ingresos totales fueron de 407,4 millones de RMB (56,1 millones de dólares estadounidenses), con una ligera disminución del 1,1% interanual, pero superando lo esperado. La compañía logró un ingreso neto de 18,9 millones de RMB (2,6 millones de dólares estadounidenses), en comparación con una pérdida neta en el Q2 2023. El ingreso neto No-GAAP aumentó a 22,2 millones de RMB (3,1 millones de dólares estadounidenses).
Entre los aspectos destacados se incluye un incremento del 22,6% en las ventas de productos médicos y servicios de mantenimiento. La empresa abrió 14 nuevas clínicas en ocho ciudades clave. Sin embargo, los usuarios activos mensuales móviles promedio disminuyeron a 1,5 millones desde 3,0 millones en el Q2 2023. Para el Q3 2024, So-Young espera ingresos totales entre 350,0 millones y 370,0 millones de RMB, lo que representa una disminución interanual del 9,2% al 4,0%.
So-Young International Inc. (Nasdaq: SY)가 2024년 2분기 재무 결과를 발표했습니다. 총 수익은 4억 740만 RMB (5610만 달러) 로, 전년 대비 1.1% 감소했지만 예상치를 웃돌았습니다. 회사는 순이익 1890만 RMB (260만 달러)를 기록하여 2023년 2분기의 순손실에서 벗어났습니다. Non-GAAP 기준 순이익은 2220만 RMB (310만 달러)로 증가했습니다.
주요 하이라이트로는 의료 제품 및 유지 보수 서비스 판매가 22.6% 증가한 점이 있습니다. 회사는 8개 주요 도시에서 14개의 새로운 클리닉을 개설했습니다. 그러나 평균 모바일 MAU는 2023년 2분기의 300만에서 150만으로 감소했습니다. 2024년 3분기 동안 So-Young은 총 수익을 3억 5000만에서 3억 7000만 RMB로 예상하며, 이는 전년 대비 9.2%에서 4.0% 감소하는 것입니다.
So-Young International Inc. (Nasdaq: SY) a annoncé ses résultats financiers pour le Q2 2024. Les revenus totaux se sont élevés à 407,4 millions de RMB (56,1 millions de dollars US), en légère baisse de 1,1% d'une année sur l'autre mais dépassant les prévisions. L'entreprise a réalisé un bénéfice net de 18,9 millions de RMB (2,6 millions de dollars US), par rapport à une perte nette au Q2 2023. Le bénéfice net Non-GAAP a augmenté pour atteindre 22,2 millions de RMB (3,1 millions de dollars US).
Parmi les points forts, on note une augmentation de 22,6% des ventes de produits médicaux et des services de maintenance. L'entreprise a ouvert 14 nouvelles cliniques dans huit villes clés. Cependant, le nombre moyen d'utilisateurs actifs mobiles a diminué à 1,5 million contre 3,0 millions au Q2 2023. Pour le Q3 2024, So-Young s'attend à des revenus totaux compris entre 350,0 millions et 370,0 millions de RMB, représentant une baisse d'année en année de 9,2% à 4,0%.
So-Young International Inc. (Nasdaq: SY) hat die finanziellen Ergebnisse für das Q2 2024 veröffentlicht. Die Gesamteinnahmen betrugen 407,4 Millionen RMB (56,1 Millionen USD), was einem leichten Rückgang von 1,1% im Jahresvergleich entspricht, jedoch die Prognose übertraf. Das Unternehmen erzielte einen Nettogewinn von 18,9 Millionen RMB (2,6 Millionen USD), verglichen mit einem Nettverlust im Q2 2023. Der Non-GAAP-Nettogewinn stieg auf 22,2 Millionen RMB (3,1 Millionen USD).
Zu den wichtigsten Highlights gehört ein Umsatzanstieg von 22,6% im Verkauf von medizinischen Produkten und Wartungsdiensten. Das Unternehmen eröffnete 14 neue Kliniken in acht wichtigen Städten. Die durchschnittlichen mobilen MAUs sanken jedoch von 3 Millionen im Q2 2023 auf 1,5 Millionen. Für das Q3 2024 erwartet So-Young Gesamteinnahmen zwischen 350,0 Millionen und 370,0 Millionen RMB, was einen Rückgang im Jahresvergleich von 9,2% bis 4,0% darstellt.
- Total revenues of RMB407.4 million (US$56.1 million) exceeded guidance
- Net income of RMB18.9 million (US$2.6 million), compared to a net loss in Q2 2023
- Non-GAAP net income increased to RMB22.2 million (US$3.1 million)
- 22.6% year-over-year increase in sales of medical products and maintenance services
- Opened 14 new clinics across eight core cities
- Beijing clinic leads in key operating metrics, including repeat customer rates and customer acquisition costs
- Total revenues decreased 1.1% year-over-year
- Average mobile MAUs decreased to 1.5 million from 3.0 million in Q2 2023
- Number of medical service providers subscribing to information services decreased to 1,174 from 1,659 in Q2 2023
- Information services and other revenues decreased 6.6% year-over-year
- Reservation services revenues decreased 16.9% year-over-year
- Q3 2024 revenue guidance suggests a 9.2% to 4.0% year-over-year decrease
Insights
So-Young's Q2 2024 results show a mixed performance. While total revenues decreased slightly by
The company's strategic shift towards medical product sales is paying off, with a significant
While the company beat its revenue guidance, the Q3 outlook suggests a potential
So-Young's Q2 results reflect the ongoing transformation in China's medical aesthetics industry. The company's pivot towards a more integrated model, including product sales and physical clinics, is a strategic response to changing market dynamics. The success of the Beijing clinic in terms of repeat customer rates and customer acquisition costs is particularly promising.
However, the decline in platform subscribers and MAUs suggests a shift in how consumers and providers interact in this space. The company's focus on upstream product development and customization could be a differentiator, but it also increases competition with established beauty brands.
The medical aesthetics market in China remains volatile, with regulatory changes and consumer sentiment shifts. So-Young's diversification strategy may provide more stability, but it also increases operational complexity. The company's ability to execute across multiple business lines will be important for long-term success.
Second Quarter 2024 Financial Highlights
- Total revenues were
RMB407.4 million (US [1]), compared with$56.1 million RMB412.1 million in the corresponding period of 2023, exceeding the high end of guidance. - Net income attributable to So-Young International Inc. was
RMB18.9 million (US ), compared with net loss attributable to So-Young International Inc. of$2.6 million RMB2.6 million in the same period of 2023. - Non-GAAP net income attributable to So-Young International Inc.[2] was
RMB22.2 million (US ), compared with non-GAAP net income attributable to So-Young International Inc. of$3.1 million RMB15.5 million in the same period of 2023.
Second Quarter 2024 Operational Highlights
- Average mobile MAUs were 1.5 million, compared with 3.0 million in the second quarter of 2023.
- Number of medical service providers subscribing to information services on So-Young's platform was 1,174, compared with 1,659 in the second quarter of 2023.
- Total number of purchasing users through reservation services was 137.5 thousand and the aggregate value of medical aesthetic treatment transactions facilitated by So-Young's platform was
RMB427.8 million .
Mr. Xing Jin, Co-Founder and Chief Executive Officer of So-Young, commented, "Our performance during the second quarter was solid with total revenue beating guidance on the back of a significant
Mr. Hui Zhao, Chief Financial Officer of So-Young, added, "Growth during the quarter was fueled by the progress we made in integrating our platform across the medical aesthetic value chain. This not only promotes the high-quality and sustainable development of the industry, but also further strengthens our market position. As we accelerate the development of our new businesses, we will continue to prudently manage costs and enhance operational efficiency. We are confident that these strategic initiatives will continue to drive sustainable growth and enhance shareholder value over the long-term."
[1] This press release contains translations of certain Renminbi (RMB) amounts into |
[2] Non-GAAP net income/(loss) attributable to So-Young International Inc. is defined as net income/(loss) attributable to So-Young International Inc. excluding share-based compensation expenses attributable to So-Young International Inc. See "Reconciliation of GAAP and Non-GAAP Results" at the end of this press release. |
Second Quarter 2024 Financial Results
Revenues
Total revenues were
- Information services and other revenues were
RMB279.2 million (US ), a decrease of$38.4 million 6.6% fromRMB298.9 million in the same period of 2023. The decrease was primarily due to a decrease in the number of medical service providers subscribing to information services on So-Young's platform. - Reservation services revenues were
RMB22.4 million (US ), a decrease of$3.1 million 16.9% fromRMB26.9 million in the same period of 2023. The decrease was primarily due to the policy change for commission rates and subsidies. - Sales of medical products and maintenance services were
RMB105.8 million (US ), an increase of$14.6 million 22.6% fromRMB86.3 million in the same period of 2023, primarily due to an increase in the order volumes for cosmetic products.
Cost of Revenues
Cost of revenues was
- Cost of services and others were
RMB101.9 million (US ), a decrease of$14.0 million 4.4% fromRMB106.5 million in the second quarter of 2023. The decrease was primarily due to a decrease in the cost of services associated with So-Young Prime. - Cost of medical products sold and maintenance services were
RMB53.2 million (US ), an increase of$7.3 million 21.3% fromRMB43.9 million in the second quarter of 2023. The increase was primarily due to an increase in costs associated with the sales of cosmetic products.
Operating Expenses
Total operating expenses were
- Sales and marketing expenses were
RMB132.3 million (US ), a decrease of$18.2 million 4.1% fromRMB137.9 million in the second quarter of 2023. The decrease was mainly due to a decrease in expenses associated with branding and user acquisition activities. Sales and marketing expenses included share-based compensation expenses ofRMB0.2 million (US ), compared with$0.0 million RMB0.8 million in the corresponding period of 2023. - General and administrative expenses were
RMB70.8 million (US ), a decrease of$9.7 million 23.3% fromRMB92.3 million in the second quarter of 2023. The decrease was primarily due to decreases in share-based compensation expenses and professional consulting fees. General and administrative expenses included share-based compensation expenses ofRMB2.0 million (US ), compared with$0.3 million RMB15.5 million in the corresponding period of 2023. The decrease in share-based compensation expenses was due to the compensation costs of the restricted share units granted in 2023, which were fully recognized by the end of the first quarter of 2024. - Research and development expenses were
RMB42.5 million (US ), a decrease of$5.8 million 18.5% fromRMB52.1 million in the second quarter of 2023. The decrease was primarily attributable to improvements in staff efficiency. Research and development expenses included share-based compensation expenses ofRMB0.8 million (US ), compared with$0.1 million RMB1.3 million in the corresponding period of 2023.
Income Tax Benefits
Income tax benefits were
Net Income/(Loss) Attributable to So-Young International Inc.
Net income attributable to So-Young International Inc. was
Non-GAAP Net Income Attributable to So-Young International Inc.
Non-GAAP net income attributable to So-Young International Inc., which excludes the impact of share-based compensation expenses attributable to So-Young International Inc., was
Basic and Diluted Earnings/(Loss) per ADS
Basic and diluted earnings per ADS attributable to ordinary shareholders were
Cash and Cash Equivalents, Restricted Cash and Term Deposits, Term Deposits and Short-Term Investments
As of June 30, 2024, cash and cash equivalents, restricted cash and term deposits, term deposits and short-term investments were
Business Outlook
For the third quarter of 2024, So-Young expects total revenues to be between
Non-GAAP Financial Measures
To supplement the financial measures prepared in accordance with generally accepted accounting principles in
Conference Call Information
So-Young's management will hold an earnings conference call on Friday, August 23, 2024, at 7:30 AM
International: | +1-412-902-4272 |
Mainland | 4001-201203 |
US: | +1-888-346-8982 |
+852-301-84992 | |
Passcode: | So-Young International Inc. |
A telephone replay will be available two hours after the conclusion of the conference call through 23:59
International: | +1-412-317-0088 |
US: | +1-877-344-7529 |
Passcode: | 3725692 |
Additionally, a live and archived webcast of this conference call will be available at http://ir.soyoung.com.
About So-Young International Inc.
So-Young International Inc. (Nasdaq: SY) is the largest and most vibrant social community in
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the
For more information, please contact:
So-Young
Investor Relations
Ms. Mona Qiao
Phone: +86-10-8790-2012
E-mail: ir@soyoung.com
Christensen
In
Ms. Dee Wang
Phone: +86-10-5900-1548
E-mail: dee.wang@christensencomms.com
In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: linda.bergkamp@christensencomms.com
SO-YOUNG INTERNATIONAL INC. | |||||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | |||||
(Amounts in thousands, except for share and per share data) | |||||
As of | |||||
December 31, | June 30, | June 30, | |||
2023 | 2024 | 2024 | |||
RMB | RMB | US$ | |||
Assets | |||||
Current assets: | |||||
Cash and cash equivalents | 426,119 | 456,927 | 62,875 | ||
Restricted cash and term deposits | 14,695 | 83,224 | 11,452 | ||
Trade receivables | 57,219 | 81,585 | 11,226 | ||
Inventories | 118,924 | 143,374 | 19,729 | ||
Receivables from online payment platforms | 23,158 | 20,819 | 2,865 | ||
Amounts due from related parties | 9,212 | 10,292 | 1,416 | ||
Term deposits and short-term investments | 900,823 | 704,979 | 97,008 | ||
Prepayment and other current assets | 171,774 | 237,267 | 32,649 | ||
Total current assets | 1,721,924 | 1,738,467 | 239,220 | ||
Non-current assets: | |||||
Long-term investments | 261,016 | 278,546 | 38,329 | ||
Intangible assets | 145,253 | 133,104 | 18,316 | ||
Goodwill | 540,693 | 540,693 | 74,402 | ||
Property and equipment, net | 116,782 | 137,162 | 18,874 | ||
Deferred tax assets | 78,034 | 80,626 | 11,095 | ||
Operating lease right-of-use assets | 118,408 | 139,885 | 19,249 | ||
Other non-current assets | 232,455 | 183,546 | 25,257 | ||
Total non-current assets | 1,492,641 | 1,493,562 | 205,522 | ||
Total assets | 3,214,565 | 3,232,029 | 444,742 | ||
Liabilities | |||||
Current liabilities: | |||||
Short-term borrowings | 29,825 | 39,713 | 5,465 | ||
Taxes payable | 56,894 | 57,567 | 7,921 | ||
Contract liabilities | 103,374 | 95,656 | 13,163 | ||
Salary and welfare payables | 86,290 | 79,716 | 10,969 | ||
Amounts due to related parties | 388 | 138 | 19 | ||
Accrued expenses and other current | 233,913 | 249,175 | 34,287 | ||
Operating lease liabilities-current | 29,739 | 27,482 | 3,782 | ||
Total current liabilities | 540,423 | 549,447 | 75,606 | ||
Non-current liabilities: | |||||
Operating lease liabilities-non current | 86,210 | 114,478 | 15,753 | ||
Deferred tax liabilities | 25,082 | 21,342 | 2,937 | ||
Other non-current liabilities | 1,536 | 1,610 | 222 | ||
Total non-current liabilities | 112,828 | 137,430 | 18,912 | ||
Total liabilities | 653,251 | 686,877 | 94,518 | ||
Shareholders' equity: | |||||
Treasury stock | (358,453) | (365,451) | (50,288) | ||
Class A ordinary shares ( | 238 | 251 | 35 | ||
Class B ordinary shares (US | 37 | 37 | 5 | ||
Additional paid-in capital | 3,080,433 | 3,065,650 | 421,847 | ||
Statutory reserves | 33,855 | 33,855 | 4,659 | ||
Accumulated deficit | (330,166) | (332,465) | (45,749) | ||
Accumulated other comprehensive income | 18,185 | 23,934 | 3,293 | ||
Total So-Young International Inc. shareholders' equity | 2,444,129 | 2,425,811 | 333,802 | ||
Non-controlling interests | 117,185 | 119,341 | 16,422 | ||
Total shareholders' equity | 2,561,314 | 2,545,152 | 350,224 | ||
Total liabilities and shareholders' equity | 3,214,565 | 3,232,029 | 444,742 |
SO-YOUNG INTERNATIONAL INC. | ||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||
(Amounts in thousands, except for share and per share data) | ||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||
June 30, | June 30, | June 30, | June 30, | June 30, | June 30, | |||||||
RMB | RMB | US$ | RMB | RMB | US$ | |||||||
Revenues: | ||||||||||||
Information services and others | 298,879 | 279,216 | 38,421 | 509,163 | 487,964 | 67,146 | ||||||
Reservation services | 26,903 | 22,356 | 3,076 | 56,584 | 45,420 | 6,250 | ||||||
Sales of medical products and maintenance services | 86,284 | 105,808 | 14,560 | 156,422 | 192,278 | 26,458 | ||||||
Total revenues | 412,066 | 407,380 | 56,057 | 722,169 | 725,662 | 99,854 | ||||||
Cost of revenues: | ||||||||||||
Cost of services and others | (106,519) | (101,853) | (14,015) | (188,019) | (176,075) | (24,229) | ||||||
Cost of medical products sold and maintenance services | (43,859) | (53,198) | (7,320) | (76,080) | (96,291) | (13,250) | ||||||
Total cost of revenues | (150,378) | (155,051) | (21,335) | (264,099) | (272,366) | (37,479) | ||||||
Gross profit | 261,688 | 252,329 | 34,722 | 458,070 | 453,296 | 62,375 | ||||||
Operating expenses: | ||||||||||||
Sales and marketing expenses | (137,921) | (132,308) | (18,206) | (250,432) | (245,564) | (33,791) | ||||||
General and administrative expenses | (92,341) | (70,799) | (9,742) | (153,855) | (155,752) | (21,432) | ||||||
Research and development expenses | (52,141) | (42,498) | (5,848) | (107,934) | (82,089) | (11,296) | ||||||
Total operating expenses | (282,403) | (245,605) | (33,796) | (512,221) | (483,405) | (66,519) | ||||||
(Loss)/Income from operations | (20,715) | 6,724 | 926 | (54,151) | (30,109) | (4,144) | ||||||
Other income/(expenses): | ||||||||||||
Investment income, net | 3,370 | 788 | 108 | 10,222 | 2,887 | 397 | ||||||
Interest income, net | 13,966 | 11,718 | 1,612 | 25,893 | 24,031 | 3,307 | ||||||
Exchange (losses)/gains | (1,579) | 16 | 2 | (1,154) | 410 | 56 | ||||||
Share of losses of equity method investee | (3,699) | (3,733) | (514) | (6,870) | (7,729) | (1,064) | ||||||
Others, net | 6,562 | 2,039 | 281 | 8,587 | 5,319 | 732 | ||||||
(Loss)/Income before tax | (2,095) | 17,552 | 2,415 | (17,473) | (5,191) | (716) | ||||||
Income tax benefits | 785 | 2,571 | 354 | 5,049 | 5,128 | 706 | ||||||
Net (loss)/income | (1,310) | 20,123 | 2,769 | (12,424) | (63) | (10) | ||||||
Net income attributable to noncontrolling interests | (1,268) | (1,182) | (163) | (2,102) | (2,236) | (308) | ||||||
Net (loss)/income attributable to So-Young International Inc. | (2,578) | 18,941 | 2,606 | (14,526) | (2,299) | (318) |
SO-YOUNG INTERNATIONAL INC. | ||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Continued) | ||||||||||||
(Amounts in thousands, except for share and per share data) | ||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||
June 30, | June 30, | June 30, | June 30, | June 30, | June 30, | |||||||
RMB | RMB | US$ | RMB | RMB | US$ | |||||||
Net (loss)/earnings per ordinary share | ||||||||||||
Net (loss)/earnings per ordinary share attributable to ordinary shareholder - | (0.03) | 0.24 | 0.03 | (0.18) | (0.03) | (0.00) | ||||||
Net (loss)/earnings per ordinary share attributable to ordinary shareholder - | (0.03) | 0.24 | 0.03 | (0.18) | (0.03) | (0.00) | ||||||
Net (loss)/earnings per ADS attributable to ordinary shareholders - basic (13 | (0.02) | 0.18 | 0.02 | (0.14) | (0.02) | (0.00) | ||||||
Net (loss)/earnings per ADS attributable to ordinary shareholders - diluted (13 | (0.02) | 0.18 | 0.02 | (0.14) | (0.02) | (0.00) | ||||||
Weighted average number of ordinary shares used in computing earnings/(loss) | 77,310,426 | 79,586,926 | 79,586,926 | 78,580,369 | 79,569,190 | 79,569,190 | ||||||
Weighted average number of ordinary shares used in computing earnings/(loss) | 77,310,426 | 79,899,412 | 79,899,412 | 78,580,369 | 79,569,190 | 79,569,190 | ||||||
Share-based compensation expenses included in: | ||||||||||||
Cost of services and others | (412) | (229) | (32) | (1,217) | (174) | (24) | ||||||
Sales and marketing expenses | (823) | (184) | (25) | (2,317) | (237) | (33) | ||||||
General and administrative expenses | (15,546) | (2,015) | (277) | (21,564) | (26,468) | (3,642) | ||||||
Research and development expenses | (1,305) | (817) | (112) | (2,182) | (1,660) | (228) | ||||||
* Both Class A and Class B ordinary shares are included in the calculation of the weighted average number of ordinary shares outstanding, basic and diluted. |
SO-YOUNG INTERNATIONAL INC. | ||||||||||||
Reconciliation of GAAP and Non-GAAP Results | ||||||||||||
(Amounts in thousands, except for share and per share data) | ||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||
June 30, 2023 | June 30, 2024 | June 30, | June 30, | June 30, | June 30, | |||||||
RMB | RMB | US$ | RMB | RMB | US$ | |||||||
GAAP (loss)/income from operations | (20,715) | 6,724 | 926 | (54,151) | (30,109) | (4,144) | ||||||
Add back: Share-based compensation expenses | 18,086 | 3,245 | 446 | 27,280 | 28,539 | 3,927 | ||||||
Non-GAAP (loss)/income from operations | (2,629) | 9,969 | 1,372 | (26,871) | (1,570) | (217) | ||||||
GAAP net (loss)/income attributable to So-Young International Inc. | (2,578) | 18,941 | 2,606 | (14,526) | (2,299) | (318) | ||||||
Add back: Share-based compensation expenses | 18,086 | 3,245 | 446 | 27,280 | 28,539 | 3,927 | ||||||
Non-GAAP net income attributable to So-Young International Inc. | 15,508 | 22,186 | 3,052 | 12,754 | 26,240 | 3,609 |
View original content:https://www.prnewswire.com/news-releases/so-young-reports-unaudited-second-quarter-2024-financial-results-302229399.html
SOURCE So-Young International Inc.
FAQ
What were So-Young's (SY) total revenues in Q2 2024?
How did So-Young's (SY) net income change in Q2 2024 compared to Q2 2023?
What was the growth rate of So-Young's (SY) medical products and maintenance services sales in Q2 2024?
How many new clinics did So-Young (SY) open in Q2 2024?